Histology and Cytology Market Insights, Competitive Landscape and Forecast Report to 2026:Grand View Research, Inc.

San Francisco, 26 April , Histology and Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Cytology [Cervical Cancer, Breast Cancer], Histology), By Region, And Segment Forecasts, 2019 – 2026

The global histology and cytology market size is expected to reach USD 30.6 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 13.7% during the forecast period. Increasing incidence of cancer coupled with growing adoption of cytological test due to its high reliability and less invasive nature as compared to biopsy is likely to drive the growth.

Furthermore, rising number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect market growth. Advancements in cytology and histology save the time for pathologists, making the service more cost-effective.

Technological advancements and launch of new products are the high impact rendering drivers for the histology and cytology market. In March 2018, Roche launched VENTANA DP 200 slide scanner. It is a high-speed slide scanner for digital pathology. The scanner reduces workflow errors and improves image quality. In March 2016, Becton, Dickinson and Company received approval from the U.S. FDA for its automated cervical cancer screening systems, namely BD Totalys MultiProcessor and BD Totalys SlidePrep. These instruments are used for gynecological specimen preparation.

In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves detection of cervical precancer. In March 2018, BD Life Sciences-Diagnostic Systems launched BD SurePath, a liquid-based cytology test in India for screening and detection of cervical cancer, precancerous lesions, and other cytological categories.

Access Full Research Report On Histology and Cytology Market Analysis:

https://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market

Further key findings from the study suggest:

  • Cytology testing led the market in 2018, attributed to high disease prevalence and adoption of the test for cervix screening. The segment is expected to maintain its position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness
  • The U.S. histology and cytology market was the largest in 2018 and is expected to maintain its dominance during the forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries
  • Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and adoption of screening tests
  • Some of the key players operating in the market are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

Browse More Reports Of This Category By Grand View Research At:  https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global histology and cytology market by type of examination and region:

Histology and Cytology Type of Examination Outlook (Revenue, USD Million, 2015 – 2026)

  • Cytology
    • Cervical Cancer
    • Breast Cancer
    • Other Cancers
  • Histology

Histology and Cytology Region Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

 

Access Full Press Release of this Report:  https://www.grandviewresearch.com/press-release/global-histology-cytology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

 

Leave a comment